Zimmer Biomet

Warsaw, United States Founded: 1927 • Age: 99 yrs
Medical devices for multiple health purposes are manufactured.
Annual revenue $8.2B Latest available
Total funding $1.7M 8 rounds
Employees 17000 Tracked headcount
Investors 1 Known backers
Products 3 Services tracked
Competitors 10 Brand Intelligence

About Zimmer Biomet

Zimmer Biomet is a company based in Warsaw (United States) founded in 1927. Zimmer Biomet has raised $1.73 million across 8 funding rounds from investors including OSTI.GOV. The company has 17,000 employees as of December 31, 2024. Zimmer Biomet has completed 24 acquisitions, including Biomet, CD Diagnostics and Cayenne Medical. Zimmer Biomet offers products and services including ROSA Robotics, Persona IQ, and ZBEdge Analytics. Zimmer Biomet operates in a competitive market with competitors including Stryker, Smith & Nephew, CipherHealth, NuVasive and ConnectiveRx, among others.

  • Headquarter Warsaw, United States
  • Employees 17000 as on 31 Dec, 2024
  • Stage Public
  • Sectors
    Healthcare
  • Email
    Locked
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
  • Legal Name Zimmer Biomet Holdings, Inc.
Operational Areas
Healthcare → Healthcare Products & Supplies Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    $8.23 B (USD)
    7.2
    as on Dec 31, 2025
  • Net Profit
    $705.2 M (USD)
    -21.97
    as on Dec 31, 2025
  • EBITDA
    $2.46 B (USD)
    -1.02
    as on Dec 31, 2025
  • Total Equity Funding
    $1.73 M (USD)

    in 8 rounds

  • Latest Funding Round
    Not available
  • Investors
  • Employee Count
    17000

    as on Dec 31, 2024

  • Investments & Acquisitions
    Biomet

    & 23 more

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

IPO & Listings of Zimmer Biomet

Zimmer Biomet is a publicly listed company on the NYSE with ticker symbol ZBH in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

Exchange: NYSE · Ticker: ZBH · Sector: Health technology · USA

Products & Services of Zimmer Biomet

Zimmer Biomet offers a comprehensive portfolio of products and services, including ROSA Robotics, Persona IQ, and ZBEdge Analytics.

Product name locked
Category locked
Primary

Surgical robotics system for precise orthopedic procedures.

Product name locked
Category locked
Locked

AI platform for patient care management and analytics.

Product name locked
Category locked
Locked

Analytics software for enhancing healthcare efficiency.

People of Zimmer Biomet

Headcount 10000+
Employee Profiles 618
Board Members and Advisors 9
Employee Profiles
People
Thea Weidemann
Talent Acquisition Lead - EMEA Commercial
People
Hege Scott
Emea North Region Collections Lead
People
Habib Massaad
Quality And Regulatory Affairs Specialist
People
Paola Velandia
Record To Report Accountant

Unlock access to complete

Board Members and Advisors
people
Arthur J. Higgins
Director
people
Syed Jafry
Director
people
Betsy J. Bernard
Director
people
Michael J. Farrell
Director

Unlock access to complete

Funding Insights of Zimmer Biomet

Zimmer Biomet has successfully raised a total of $1.73M across 8 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

Investors in Zimmer Biomet

Zimmer Biomet has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include OSTI.GOV.

All
Institutional
Investor Description Founded Year Domain Location
Scientific and technical information is managed and disseminated by OSTI.GOV.
Locked Locked Locked
Premium access

Investor details for Zimmer Biomet

Investor domains, locations, round participation, and complete history require an active premium plan.

  • Investor domains
  • Investor locations
  • Funding rounds
  • Participation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Zimmer Biomet

Zimmer Biomet has strategically engaged in corporate development activities, having acquired 24 companies. Notable acquisitions include Biomet, CD Diagnostics and Cayenne Medical.

Investments
Premium access

Investment portfolio details for Zimmer Biomet

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Acquisitions
Company Name Description Domain Location Founded Year Amount
Personalized orthopedic care is provided through robotics and implants.
Locked Locked 2016 Locked
Collagen-based regenerative matrices for soft tissue repair are provided.
Locked Locked 2014 Locked
Surgical guidance systems for orthopedic surgeries are developed.
Locked Locked 2012 Locked
Premium access

Complete acquisition details for Zimmer Biomet

Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.

  • Transaction dates
  • Acquired stakes
  • Disclosed values
  • Domains and locations

Verified entity values are shown only after access is granted.

Financial Statements - Zimmer Biomet

Premium access

Detailed financials for Zimmer Biomet

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Zimmer Biomet Comparisons

Zimmer Biomet Primary company
Description
Medical devices for multiple health purposes are manufacture...
Location
Warsaw, United States
Founded Year
1927
Annual Revenue
$8.23 B (USD)
Net Profit
$705.2 M (USD)
EBITDA
$2.46 B (USD)
Employees
17,000
As of 2024
Premium access

Peer comparison for Zimmer Biomet

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Zimmer Biomet

Zimmer Biomet operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Stryker, Smith & Nephew, CipherHealth, NuVasive and ConnectiveRx, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
3D-printed orthopedic products are manufactured for medical applications.
Locked Locked Locked
Manufacturer of knee, hip and shoulder joint replacements
Locked Locked Locked
SaaS based tools for patient engagement
Locked Locked Locked
Smart surgical devices for spinal surgery are developed.
Locked Locked Locked
Provider of patient engagement and prior authorization solutions
Premium access

Detailed competitors of Zimmer Biomet

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Zimmer Biomet

Premium access

Complete news archive for Zimmer Biomet

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Zimmer Biomet

Zimmer Biomet was founded in 1927 and raised its 1st funding round 77 years after it was founded.

Zimmer Biomet is headquartered in Warsaw, United States.

Zimmer Biomet is a funded company, having raised a total of $1.73M across 8 funding rounds to date.

As of Dec 31, 2024, the latest employee count at Zimmer Biomet is 17,000.

Annual revenue of Zimmer Biomet is $8.23B as on Dec 31, 2025.

Zimmer Biomet was founded in 1927 in Warsaw, United States, where operations in the medical devices sector are centered. A range of orthopedic and surgical products is produced for applications in orthopedics, spine, trauma, and dental health. The company serves global markets from its U.S. base. In 2022, annual revenues of 7.11 billion were achieved, alongside a net profit of 0.45 billion.

Zimmer Biomet's top competitors include Stryker, Hyro and NuVasive.

Zimmer Biomet offers ROSA Robotics, Persona IQ, and ZBEdge Analytics.

Yes, Zimmer Biomet is publicly traded on NYSE under the ticker symbol ZBH.

Zimmer Biomet has made 24 acquisitions, including Biomet, CD Diagnostics, and Cayenne Medical.

Zimmer Biomet has 1 investor. Key investors include OSTI.GOV.

The ticker symbol of Zimmer Biomet is ZBH on NYSE.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available